The expression of syndecan-1 in psoriatic epidermis by Tomas, Davor et al.
Arch Dermatol Res (2008) 300:393–395
DOI 10.1007/s00403-008-0848-z
123
SHORT COMMUNICATION
The expression of syndecan-1 in psoriatic epidermis
Davor Tomas · Majda VubiT · Mirna Kitum · 
Boqo Krunlin 
Received: 10 January 2008 / Revised: 19 February 2008 / Accepted: 11 March 2008 / Published online: 2 April 2008
© The Author(s) 2008
Abstract Psoriasis is a chronic inXammatory skin disease
characterized by exaggerated keratinocyte proliferation.
Current opinion indicates that psoriasis is driven by T cell-
mediated immune responses targeting keratinocytes. How-
ever, psoriasis cannot be explained solely on the basis of T-
cell activation, and it is likely that an intrinsic alteration in
epidermal keratinocytes plays a very important role in dis-
ease expression. Syndecans comprise a major family of cell
surface heparan sulfate proteoglycans. Several studies indi-
cate their role in adhesion, cell-extracellular matrix interac-
tions, migration, keratinocyte proliferation and
diVerentiation, inXammation, and wound healing. To deter-
mine the expression of syndecan-1 in psoriasis, skin sam-
ples from 29 patients with fully developed psoriasis and
skin samples from 14 healthy volunteer persons with no
personal or family history of psoriasis were immunohisto-
chemically examined using monoclonal antibody against
syndecan-1. The expression of syndecan-1 was analyzed in
whole mount section of psoriatic and non-psoriatic skin
biopsies under high magniWcation (400£). In addition, the
intensity and topography of reaction in the cell, as well as
localization of positive cells in the epidermis were evalu-
ated. Strong syndecan-1 reactivity in epidermal cells in all
non-psoriatic and psoriatic samples was observed. Statisti-
cal analysis showed no signiWcant diVerences between two
analyzed groups (P > 0.05). In normal skin syndecan-1 was
expressed in full thickness of the epidermis. The strongest
reaction was observed in membranes and intercellular junc-
tions of spinous and granular layer while basal cells showed
weaker expression that was conWned to cytoplasm. In psori-
atic skin syndecan-1 was expressed in the membrane and
intercellular junction of cells located in thickened and elon-
gated rete ridges of the epidermis. The strongest reaction
was in basal and suprabasal layers and expression dimin-
ished through spinous layer. Cells in spinous layer lose
syndecan-1 expression, which is opposite pattern to normal
skin. Our results suggest that aberrant skin expression of
syndecan-1 may be involved in the development of psoriasis.
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Psoriasis is a chronic inXammatory skin disease character-
ized by exaggerated keratinocyte proliferation. It is esti-
mated that the prevalence of psoriasis varies from 1 to 2%
and increases with age. Current opinion indicates that psori-
asis is driven by T cell-mediated immune responses target-
ing keratinocytes. However, psoriasis cannot be explained
solely on the basis of T-cell activation, and it is likely that
an intrinsic alteration in epidermal keratinocytes plays a
very important role in disease expression [4].
Syndecans comprise a major family of cell surface hepa-
ran sulfate proteoglycans. Syndecans at the cell surface
function as coreceptors by binding to ligands and increas-
ing ligand concentration in the pericellular vicinity of their
signaling receptors. Several studies indicate their role in
adhesion, cell-extracellular matrix interactions, migration,
keratinocyte proliferation and diVerentiation, inXammation,
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and wound healing. In adult tissues, syndecan-1 is predom-
inantly expressed by epithelial cells and plasma cells, and is
expressed to a lesser degree by other cells types (e.g. Wbro-
blasts, endothelial cells) [1].
To determine the expression of syndecan-1 in psoriasis,
skin samples from 29 patients (17 women and 12 men,
average age 47.3 years) with fully developed psoriasis and
skin samples from 14 healthy volunteer persons (eight
women and six men, average age 49.8 years) with no per-
sonal or family history of psoriasis were immunohisto-
chemically examined using monoclonal antibody against
syndecan-1 (CD138, clone MI15, dilution 1:25, DAKO,
Denmark). Immunohistochemical analysis was performed
following microwave streptavidin immunoperoxidase
(MSIP) protocol on DAKO TechMate™ Horizon auto-
mated immunostainer (DAKO). A sample of plasmacytoma
that was strongly positive for syndecan-1 was used as a
positive control. The diagnosis of psoriasis was histologi-
cally conWrmed in all cases and each specimen was re-eval-
uated by three pathologists (D.T., M.V. and B.K.). None of
the patients had received any topical treatment for at least
1 month prior the study. Skin samples of both groups mea-
sured between 0.3 and 0.8 cm (average 0.54 cm). The
expression of syndecan-1 was analyzed in whole mount
section of psoriatic and non-psoriatic skin biopsies under
high magniWcation (400£). In addition, the intensity and
topography of reaction in the cell, as well as localization of
positive cells in the epidermis were evaluated. Statistical
analysis was performed using 2 test. The level of signiW-
cance was set at P <0 . 0 5 .
Strong syndecan-1 reactivity in epidermal cells in all
non-psoriatic and psoriatic samples was observed
(Table 1). Statistical analysis showed no signiWcant diVer-
ences between two analyzed groups (P > 0.05). In addition,
dermal appendages and some endothelial and inXammatory
cells were also positive. In normal skin syndecan-1 was
expressed in full thickness of the epidermis. The strongest
reaction was observed in membranes and intercellular junc-
tions of spinous and granular layer while basal cells showed
weaker expression that was conWned to cytoplasm (Fig. 1a).
In psoriatic skin, syndecan-1 was expressed in the mem-
brane and intercellular junction of cells located in thickened
and elongated rete ridges of the epidermis (Fig. 1b). The
strongest reaction was in basal and suprabasal layers and
expression diminished through spinous layer (Fig. 1c).
Cells in most upper part of spinous layer showed no expres-
sion of syndecan-1 (Fig. 1d).
In our study, syndecan-1 was expressed in all samples of
normal skin. The strongest reaction was in suprabasal, diVer-
entiating epidermal cells which are consistent with previous
investigations [2, 6, 8]. To our knowledge, there are no reports
about expression of syndecan-1 in psoriasis. We observed
strong syndecan-1 expression in all 29 psoriatic samples, but
the pattern of expression was diVerent compared to normal
skin. The strongest expression was in proliferating basal and
suprabasal layers and expression diminished with cell diVer-
entiation. Cells in spinous layer lose syndecan-1 expression,
which is of opposite pattern to normal skin.
A role of syndecan-1 in wound healing, epidermal cell
proliferation and migration is under extensive research [3,
5, 7, 9]. Stepp et al. [9] recently reported that syndecan-1
knockout mice display impaired proliferation and migration
of corneal keratinocytes in eye abrasion wound healing.
The wounded syndecan-negative corneas failed to initiate
proliferative burst 24 h after wounding. In addition, the
migration of corneal cells was hampered by the absence of
syndecan-1 [9]. Elenius et al. [5], studied wound healing in
mice that overexpress syndecan-1 in several tissues, includ-
ing skin and blood. The elevated levels of shed syndecan-1
ectodomain in these animals inhibit booth re-epithelization
and remodeling of the newly laid matrix in dermis [5]. Ojeh
et al. [7] in their investigation, showed role of syndecan-1
in regulation of keratinocytes proliferation during skin
development and wound healing. They generated trans-
genic mice that overexpress syndecan-1 in the basal layer
of the epidermis that harbors epidermal stem cells and tran-
sit amplifying cells. Transgenic mice exhibited hyperprolif-
erative skin lesions that were characterized by normal
corniWed layer, occasional parakeratosis in the granular
layer, and increased number of spinous cell layers. The
number of suprabasal cell layers was increased and Xatten-
ing and anucleation of the cells were delayed but terminal
diVerentiation was preserved. The extent of the hyperprolif-
erations varied between diVerent skin locations and
between individual mice. Some lesions also contained
localized areas of remarkably thickened epidermis that
involved some downgrowth into the dermis [7]. Similarities
of lesion that exhibited transgenic mice with psoriatic
Table 1 The intensity of syndecan-1 expression in psoriatic and non-
psoriatic skin
a To evaluate the level of syndecan-1 expression, the percentage of
positive cells and the staining intensity were graded on a scale of 0–3.
Staining percentage was labeled as: 0 = 0% cells; 1 = 1–33% positive
cells; 2 = 34–66% positive cells; and 3 = more than 66% positive cells.
Staining intensity was denoted as: 0 = no staining; 1 = weak staining;
2 = moderate staining; 3 = strong staining. For each sample, the stain-
ing percentage and staining intensity scores were multiplied to give
staining index. Immunohistochemical staining index (ISI) was labeled
as: 0 = zero; 1–3 = low; 4–6 = moderate; and 9 = high
Psoriatic skin (%) Non-psoriatic skin (%)
ISI 0a 0 (0) 0 (0)
ISI 1a 0 (0) 0 (0)
ISI 2a 0 (0) 0 (0)
ISI 3a 29 (100) 14 (100)
Total 29 (100) 14 (100)Arch Dermatol Res (2008) 300:393–395 395
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lesion are remarkable. Increased number of suprabasal and
spinous cell layers, delayed Xattening and anucleation, para-
keratosis and remarkably thickened epidermis with down-
growth into the dermis are all histological characteristics of
psoriatic skin. In addition, in our investigation, similar
expression of syndecan-1 in psoriatic skin and transgenic
mice was also observed. The strongest expression of synd-
ecan-1 in psoriasis was in proliferative basal cell layer like
in transgenic mice and expression diminished through spi-
nous to corniWed layer of the epidermis [7].
Our results suggest that aberrant skin expression of
syndecan-1 may be involved in the development of psoria-
sis. Further studies on larger patient series and in various
stages of psoriatic lesions are welcome.
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tive Commons Attribution Noncommercial License which permits any
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Fig. 1 a In non-psoriatic skin 
syndecan-1 was expressed in full 
thickness of the epidermis. The 
strongest reaction was observed 
in membranes and intercellular 
junctions of spinous and granu-
lar layer. The basal cells in non-
psoriatic skin showed weaker 
expression of syndecan-1 that 
was conWned to cytoplasm. b In 
psoriatic skin syndecan-1 was 
expressed in the membrane and 
intercellular junction of cells lo-
cated in thickened and elongated 
rete ridges of the epidermis. 
c The strongest reaction was in 
basal and suprabasal layers and 
expression diminished through 
spinous layer. d Cells in most 
upper part of spinous layer in 
psoriatic skin showed no expres-
sion of syndecan-1 (the bar in 
b indicates 200 m. a, c and 
d are of the same magniWcation, 
and bars indicate 50 m)